MoonLake Immunotherapeutics Financial Overview
MoonLake Immunotherapeutics's market cap is currently $987.10M. The company's EPS TTM is $-1.1; its P/E ratio is -4.16; MoonLake Immunotherapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.
